Researchers at the University of Birmingham have discovered that a modified version of Ecstasy (MDMA) may have great cancer-busting potential, fighting off myeloma, lymphoma, and leukemia.
Mark Johanson
Aug 19, 2011
A government advisory panel unanimously approved an experimental drug, Adcetris, from Bothell, WA.-based drug maker, Seattle Genetics, serving as the company's first commercial drug approved by the U.S. Food and Drug Administration.
IBT Staff Reporter
Jul 15, 2011
The top pre-market NASDAQ Stock Market gainers are: Asia Entertainment & Resources, Google, Sino Clean Energy, Vical, and Carrizo Oil & Gas. The top pre-market NASDAQ Stock Market losers are: Seattle Genetics, Qlik Technologies, Logitech International, ICAgen, and Corinthian Colleges.
Balasubramanyam Seshan
Jul 15, 2011
The top after-market NASDAQ Stock Market gainers are: Google, Vical, Asia Entertainment & Resources, Extreme Networks, and Resources Connection. The top after-market NASDAQ Stock Market losers are: FLIR Systems, Life Partners Holdings, Seattle Genetics, Shengkai Innovations, and Xyratex.
Balasubramanyam Seshan
Jul 15, 2011
FDA follow-up study on silicone-gel breast implants returned to market for patients in 2006 concludes they are safe, but won't last forever.
David Magee
Jun 23, 2011
A man who died last year of lung disease while inhaling toxic debris when the World Trade Center collapsed has been added to the list of victims killed in the Sept. 11 attacks, the New York City Chief Medical Examiner's office said on Friday.
IBT Staff Reporter
Jun 18, 2011
Dying wish is to 'make everyone sign up to be a bone marrow donor'
Ellen Killoran
Jun 09, 2011
The microwave radiations emitted through mobiles phones might cause cancer a warning issued for the first time by the World Health Organization (WHO). The UN health body has listed risks that were quite alarming since it affects the youngsters and children, the most.
Ankita Mehta
Jun 04, 2011
A lawyer for accused war criminal Ratko Mladic claim their client was treated for cancer in a hospital in Belgrade Serbia two years ago, ahead of his first appearance in a UN court at The Hague in The Netherlands.
Palash Ghosh
Jun 02, 2011
A slideshow which showcases Microsoft co-founder and billionaire Paul Allen's many indulgences:
IBT Staff Reporter
Apr 21, 2011
Roche Holding AG's arthritis and cancer drug, Rituxan, received approval from the U.S. Food and Drug Administration (FDA) to treat two rare disorders that cause blood vessel inflammation.
IBT Staff Reporter
Apr 20, 2011
A U.S. Environmental Protection Agency draft assessment of the potential health effects associated with formaldehyde exposure needs substantial revision, says a new report from the National Research Council, which recommends improvements for EPA's final assessment.
IBT Staff Reporter
Apr 12, 2011
Shares of Spectrum Pharmaceuticals, Inc. (SPPI) touched a new 52-week high of $7.60 on Thursday. The company posted a decline in fourth quarter earnings as last year period recorded stock warrant gains, but came ahead of Street view.
Balasubramanyam Seshan
Mar 10, 2011
The top pre-market NASDAQ stock market gainers are: ZST Digital Networks, Flow International, Spreadtrum Communications, Allos Therapeutics, and G-III Apparel Group. The top pre-market NASDAQ stock market losers are: Cerus, Energy Recovery, Marvell Technology Group, EV Energy Partners, and WPP.
Balasubramanyam Seshan
Mar 04, 2011
The top after-market NASDAQ stock market gainers are: Spreadtrum Communications, Identive Group, Allos Therapeutics, Flow International, and SuperMedia. The top after-market NASDAQ stock market losers are: Energy Recovery, Marvell Technology Group, Dot Hill Systems, BSQUARE, and EV Energy Partners.
Balasubramanyam Seshan
Mar 04, 2011
The top after-market NASDAQ stock market gainers are: Tuesday Morning, Radvision, Spectrum Pharmaceuticals, Skyworks Solutions, and China Valves Technology. The top after-market NASDAQ stock market losers are: Sify Technologies, Rediff.com India, Woodward Governor, Acacia Research, and Marshall Edwards.
Balasubramanyam Seshan
Jan 25, 2011
The top pre-market NASDAQ stock market gainers are: Radvision, Cytori Therapeutics, Allos Therapeutics, Pharmaceutical Product Development, ICAgen, and eBay. The top pre-market NASDAQ stock market losers are: MannKind, F5 Networks, Riverbed Technology, Isle of Capri Casinos, and Skyworks Solutions.
Balasubramanyam Seshan
Jan 20, 2011
The top after-market NASDAQ stock market gainers are: Orthovita, Allos Therapeutics, ICAgen, Biodel, and eBay. The top after-market NASDAQ stock market losers are: MannKind, F5 Networks, Westell Technologies, Internap Network Services, and Riverbed Technology.
Balasubramanyam Seshan
Jan 20, 2011
German researchers say they have cured a man of HIV infection that could prove to be a scientific advance but researchers familiar with the work feel it is not necessarily a treatment advance.
IBT Staff Reporter
Dec 15, 2010
The top pre-market NASDAQ stock market gainers are: Cytori Therapeutics, Spectrum Pharmaceuticals, Zix, Powerwave Technologies, optionsXpress Holdings, Interactive Brokers Group, Qiao Xing Universal Resources, Seagate Technology, and Fifth Third Bancorp.
Balasubramanyam Seshan
Dec 07, 2010
The top after-market NASDAQ stock market gainers are: Spectrum Pharmaceuticals, First Place Financial, Cytokinetics, Photronics, FX Energy, Ultralife, Healthways, Rodman & Renshaw Capital Group, optionsXpress Holdings, and SuperMedia.
Balasubramanyam Seshan
Dec 07, 2010
Microsoft Corp co-founder Paul Allen, who has been treated for non-Hodgkin's lymphoma, said on Thursday he is committing most of his estimated $13.5 billion fortune to philanthropy after his death.
IBT Staff Reporter
Jul 15, 2010
